AN ENDOCRINE CLINIC'S PERSPECTIVE AND EXPERIENCE WITH THE ABBOTT FREESTYLE LIBRE CGM

On September 27, the U.S. Food and Drug Administration approved the FreeStyle Libre Flash Glucose Monitoring System® (FSL FGM; Abbott, Chicago, IL)) for use by patients to self-monitor their own glucose levels without using blood samples to calibrate (1).With the advent of continuous glucose monitor...

Ausführliche Beschreibung